Works matching IS 14642662 AND DT 2024 AND VI 25 AND IP 2


Results: 19
    1

    Issue Information.

    Published in:
    HIV Medicine, 2024, v. 25, n. 2, p. 1, doi. 10.1111/hiv.13664
    Publication type:
    Article
    2
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Long‐term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir‐containing antiretroviral therapy.

    Published in:
    HIV Medicine, 2024, v. 25, n. 2, p. 291, doi. 10.1111/hiv.13561
    By:
    • Begré, Lorin;
    • Boyd, Anders;
    • Salazar‐Vizcaya, Luisa;
    • Suter‐Riniker, Franziska;
    • Béguelin, Charles;
    • Rockstroh, Jürgen K.;
    • Günthard, Huldrych F.;
    • Calmy, Alexandra;
    • Cavassini, Matthias;
    • Stöckle, Marcel;
    • Schmid, Patrick;
    • Bernasconi, Enos;
    • Levrero, Massimo;
    • Zoulim, Fabien;
    • Wandeler, Gilles;
    • Rauch, Andri
    Publication type:
    Article
    14

    Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (START) study.

    Published in:
    HIV Medicine, 2024, v. 25, n. 2, p. 212, doi. 10.1111/hiv.13556
    By:
    • Cozzi‐Lepri, Alessandro;
    • Dunn, David;
    • Tostevin, Anna;
    • Marvig, Rasmus L.;
    • Bennedbæk, Marc;
    • Sharma, Shweta;
    • Kozal, Michael J.;
    • Gompels, Mark;
    • Pinto, Angie N.;
    • Lundgren, Jens;
    • Baxter, John D.
    Publication type:
    Article
    15
    16
    17
    18
    19

    Issue Information.

    Published in:
    HIV Medicine, 2024, v. 25, n. 2, p. 163, doi. 10.1111/hiv.13503
    Publication type:
    Article